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a  b  s  t  r  a  c  t
Human  monocytes  are  commonly  deﬁned  and  discriminated  by  the  extent  of  their  cell surface  expression
of CD14  and  CD16,  with  associated  differences  in  function  and  phenotype  related  to  the  intensity  of
expression  of these  markers.  With  increasing  interest  into  the  function  and  behaviour  of monocytes,  it
is important  to  have  a clear  understanding  of how  differing  strategies  of  analysis  can  affect  results  and
how  different  protocols  and  population  backgrounds  can affect  this  highly  morphogenic  cell type.
Using  PBMCs  from  populations  with  differing  ethnicities  and  histories  of  parasite  exposure  we  have
characterized  monocyte  phenotype  based  on  intensity  of CD14  and  CD16  expression.  Using  the  surface
markers  HLA-DR,  CCR2  and  CX3CR1,  we  compared  monocyte  phenotype  between  populations  and  further
assessed  changes  in monocytes  with  freezing  and  thawing  of PBMCs.
Our  results  reveal  that  there  is a  progression  of  surface  marker  expression  based  on  intensity  of  CD14 or
CD16  expression,  stressing  the  importance  of  careful  gating  of monocyte  subtypes.  Freezing  and  thawing
of the  PBMCs  has  no  effect  generally  on  the monocytes,  although  it does  lead  to a  decrease  in  CD16 and
CX3CR1  expression.  We  show  that  there  are  differences  in  the  monocyte  populations  based  on  ethnicity
and history  of  exposure  to  the  common  parasites  Plasmodium  falciparum  and  Schistosoma  haematobium.
This study  highlights  that  blood  monocytes  consist  of  a continuous  population  of cells,  within  which
the  dominant  phenotype  may  vary  dependent  on  the  background  of  the  study  population.  Comparing
results  from  monocyte  studies  therefore  needs  to be done  with  great  care,  as ethnic  background  of  donor
population,  gating  strategy  and  processing  of PBMCs  may  all have an  effect  on outcome  of  monocyte
phenotype.
© 2013 Published by Elsevier B.V.
1. Introduction22
Peripheral blood monocytes, which represent around 10% of23
circulating leukocytes in humans, are recognized as the largest24
pool of circulating progenitor cells and form a vital part of the25
immune system [1,2]. The enormous heterogeneity in human26
monocyte size, morphology, phagocytic function and cell adhe-27
sion was ﬁrst described in 1989 [3] and was quickly followed by28
Abbreviations: LPS, lipopolysaccharide; MHC, major histocompatibility com-
plex; PBMC, peripheral blood mononuclear cell; LN2, liquid nitrogen; MFI, mean
ﬂuorescence index; FSC, forward scatter; SSC, side scatter; NK, natural killer; ELISA,
enzyme linked immunosorbent assay; SWAP, soluble worm antigen preparation;
ANOVA, analysis of variance; DP, double positive; SEM, standard error of mean.
∗ Corresponding author. Tel.: +44 1316507706.Q2
E-mail addresses: l.j.appleby@sms.ed.ac.uk, l.j.appleby-1@sms.ed.ac.uk,
laurajappleby@gmail.com (L.J. Appleby).
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multiple attempts to discriminate monocyte subtypes. Recently 29
new nomenclature was  suggested by an expert panel in Bres- 30
cia, Italy to deﬁne three subsets according to expression of CD14 31
and CD16 [4].  The major subset consists of CD14highCD16negative 32
monocytes (CD14++CD16−), while the CD16 expressing monocytes 33
are usually divided into a CD14highCD16low (CD14++CD16+) and 34
a CD14lowCD16high (CD14+CD16++) subset. These groupings can 35
identify monocytes that differ in surface expression of chemokine 36
markers, major histocompatibility complex (MHC) class II expres- 37
sion and in their capacity to produce cytokines and phagocytose 38
microbial particles [1,5–8].  However, while there have been some 39
in-depth genetic and proteomic analyses of monocyte functions 40
and cell markers [1,6,9],  there is still no universally accepted 41
demarcation of these subsets based on phenotypic markers [9].  Fur- 42
thermore, there is no visible clustering of the cell subsets based 43
on the CD14 and CD16 surface markers, instead the two markers 44
form a spectrum of expression levels potentially contributing to 45
variation between experiments [4,7,10]. Differential expression of 46
chemokine and scavenger receptors indicates a functional potential 47
0165-2478/$ – see front matter ©  2013 Published by Elsevier B.V.
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Table  1
Study cohorts and description.
Study Donor ethnicity Origin (urban/rural) N
Whole monocyte phenotype African (Zimbabwe) Rural 62
Effects of cryopreservation on monocyte phenotype African (other) Urban 5
Caucasian 4
Effects of genetics or exposure on monocyte phenotype Europe Urban 21
African (Zimbabwe) Rural 21
in terms of trafﬁcking to sites of infection and inﬂammation. Indeed,48
monocyte migration and trafﬁcking has been observed to vary49
between subsets based on expression of CCR2 and CX3CR1 [11].50
Another feature of monocytes is their ubiquitous expression of51
the MHC  class II surface receptor, HLA-DR, which is frequently52
used to distinguish between CD16 expressing monocytes and CD1653
expressing NK cells [12]. As a receptor that is involved in antigen54
presentation [9],  it is often considered an activation marker [13–15]55
and indicates functional differences for the monocyte subsets as56
well as subset activation status [12].57
Thus far, the majority of human monocyte studies have taken58
place using volunteers of Caucasian background and in high income59
countries where pathologies arising from non-communicable dis-60
eases such as atherosclerosis, liver cirrhosis and asthma dominate61
[16]. This means that, despite the demonstration of the impor-62
tance of monocytes in experimental models of parasitic diseases63
[2,17,18], comparatively little is known about the nature, pheno-64
type and development of monocytes in people exposed to tropical65
infectious diseases. Furthermore the majority of studies investi-66
gating monocyte phenotype and function use whole blood or fresh67
PBMCs rather than cryopreserved peripheral blood mononuclear68
cells (PBMCs). Cryopreservation of PBMCs is an indispensable tool69
for longitudinal clinical studies as well as during ﬁeldwork when70
samples have to be stored and transported from the collection71
point to a laboratory. Furthermore, the capability to retrospectively72
analyze specimens from the same patient allows analysis of large73
sample populations, monitoring of clinical status over time or after74
treatment and improves accuracy while reducing within-patient as75
well as interassay variability [19,20]. To date, studies determining76
the effects of cryopreservation on PBMCs have focused on cell com-77
partment changes [21] or maturation pathways [22], but no studies78
have been conducted on the effects of cryopreservation on the cell79
phenotype which is central to the function of the monocytes.80
In this study our aims were (1) to determine changes in expres-81
sion levels of cell surface markers occurring within the monocyte82
cell population dependent on CD14 and CD16 expression inten-83
sity, (2) to assess the stability of these markers during processes84
involved in freezing and storage, and ﬁnally, (3) to determine if dif-85
ferences occur in the proportion and phenotype of monocytes in the86
different sub-populations between Caucasian individuals who have87
been exposed to a typical western lifestyle, and African individuals88
who are lifelong residents of a rural helminth endemic area.89
2. Methods90
2.1. Ethical statement91
Written consent was obtained from all participants or their92
guardians prior to enrolling in the study. Local ethical approval93
was given and local review board guidelines adhered to. The cohort94
of rural Africans was part of a larger study investigating the epi-95
demiology and immunology of human schistosomiasis that was96
conducted in the Mashonaland East Province of Zimbabwe. Per-97
mission to conduct the study in the region was obtained from98
the Provincial Medical Director. Institutional and ethical approval99
was received from the University of Zimbabwe and the Medical100
Research Council of Zimbabwe respectively. At the beginning of 101
the study, parents and guardians of participating children had the 102
aims and procedures of the project explained fully in the local lan- 103
guage, Shona, and written consent was  obtained from participants’ 104
parents/guardian before enrolment into the study. After collection 105
of all samples, all participants and their parents/guardians were 106
offered anthelmintic treatment with the recommended dose of 107
praziquantel (40 mg/kg of body weight). 108
2.2. Study populations 109
To address the different questions, three different cohorts were 110
used, which are described in Table 1. For the purposes of phenotyp- 111
ing monocytes for cell surface expression patterns of the markers 112
CCR2, CX3CR1 and HLA-DR, a cohort of 62 individuals living in a 113
rural area where Schistosoma haematobium is prevalent was  used. 114
All participants were from the Murehwa district in north east- 115
ern Zimbabwe. All individuals recruited into each study were S. 116
haematobium and co-infection negative and had never received 117
anti-helminthic treatment. In addition there is little or no infection 118
with Schistosoma mansoni, soil transmitted helminths and malaria 119
transmission is sporadic and seasonal [23]. The residents of the area 120
are subsistence farmers with frequent contact with infected water 121
for purposes of irrigation, bathing, washing and collecting water 122
(assessed by questionnaire) [24]. 123
In order to investigate the effects of cryopreservation on mono- 124
cyte phenotype and cell numbers, peripheral blood from nine 125
African or Caucasian volunteers, currently living in urban envi- 126
ronments, was  used to compare monocytes from freshly isolated 127
PBMCs to those from cryopreserved PBMCs. For evaluation of differ- 128
ences that genetics and lifetime exposure to infection may  have on 129
monocyte phenotype, PBMCs from 21 Africans who were exposed 130
to, but negative for, helminth, malaria and HIV co-infections were 131
compared to 21 age and sex matched Caucasians with no reported 132
exposure to these pathogens. Table 2 shows the ages (mean, median 133
and range) of each of the populations (rural African and Caucasian) 134
used in background comparisons. In order to check for effects of 135
genetic background vs pathogen exposure, ﬁve donors of African 136
origin (Kenya (n = 4) and Zimbabwe (n = 1)) were recruited to the 137
study. All ﬁve donors had grown up in an urban environment. 138
2.3. Parasitology 139
Parasite infection status was  determined in the Zimbabwean 140
participants through examination of at least 2 stool and 2 urine 141
samples collected on 3 consecutive days and a single blood sam- 142
ple. The urine samples were used for microscopic diagnosis of S. 143
haematobium infection using the standard urine ﬁltration method 144
[25], while the stool sample was used for microscopic diagnosis of 145
intestinal helminths and S. mansoni infection using the Kato–Katz 146
method [26]. Blood smears were microscopically examined for 147
Plasmodium falciparum infection, and results conﬁrmed using the 148
rapid Paracheck test, (Orchid Biomedical Systems, Goa, India) and 149
serologically tested for HIV status using the DoubleCheckGoldTM 150
HIV1&2 test kit (Orgenics, Ltd., Yavne Israel). All Zimbabwean 151
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Table  2
Age of rural African and Caucasian cohorts.
Rural African Caucasian
N Mean Median Range (min–max) N Mean Median Range (min–max)
M 6 23 17 15–55 10 33.6 31 26–53
F  15 31.1 34 17–44 11 33 29 25–54
Total 21 28.8 28 15–55 21 33.3 30 25–54
donors were selected to be S. haematobium,  S. mansoni, soil trans-152
mitted helminth, malaria and HIV negative.153
2.4. Blood collection and isolation of PBMC154
Approximately 30 ml  of venous blood was collected in hep-155
arinised tubes from all donors. PBMC were isolated through density156
centrifugation using LymphoprepTM (Axis-Shield, Cambridgeshire,157
UK). Heparinised plasma was collected and stored at −80 ◦C until158
assay. PBMCs were counted and resuspended at approximately159
1 × 107 c/ml in freezing media (90%DMSO, 10%FCS) for cryopreser-160
vation and immediately cooled to −80 ◦C in a freezing container161
(Nalgene Nunc, International) prior to placing in liquid nitrogen162
(LN2) until assay. For analysis of fresh PBMCs a further 8 ml of163
venous blood was collected from each individual on the day of164
thawing and processing cryopreserved samples. The time between165
processing PBMCs for cryopreservation and processing PBMCs for166
a fresh analysis was no more than a month in any case. Pro-167
cessing was performed in the manner described and cells were168
suspended at 5 ×106 cells/ml. Surface staining was performed169
straight away in the same manner as for cryopreserved cells as170
described.171
2.5. Phenotyping of monocytes172
Cryopreserved PBMCs were thawed straight from LN2 in a 37 ◦C173
water bath until only a small crystal remained. The contents of174
the vial were slowly added to complete media (RPMI 1640), sup-175
plemented with 10% heat inactivated FCS, 2 mM l-glutamine and176
100 U penicillin/streptomycin (all Lonza, Verviers, Belgium). Cells177
were washed twice with complete media, counted in trypan blue178
(Sigma–Aldrich, Dorset, UK). Cells were washed in PBS (Lonza,179
Verviers, Belgium) and resuspended at 5 × 105 cells per stain for180
each staining panel.181
Fresh and thawed cells for staining were incubated with 10%182
FCS at 4 ◦C for 10 minutes prior to staining and stained with183
Alexa488-conjugated anti-CD14 (clone M5E2), PE-Cy7-conjugated184
HLA-DR (clone L243; all from BD Biosciences, San Jose, CA), Paciﬁc185
Blue-conjugated CD16 (clone CB16; eBiosciences, San Diego, CA),186
Alexa647-conjugated CX3CR1 (clone 2A9-1; BioLegend, San Diego,187
CA), PerCP-conjugated CCR2 (clone 48607; RnD Systems, Min-188
neapolis, MN)  or the relevant isotype control for 30 min  at 4 ◦C.189
Unbound antibodies were washed off and cells were resuspended190
in PBS prior to acquisition of at least 50,000 live events on a BD191
FACS LSR II (BD Biosciences, San Jose, CA). Compensation was per-192
formed prior to acquisition of each experiment using BD FacsComp193
beads (BD Biosciences, San Jose, CA). Analysis was  performed using194
FlowJo software (TreeStar, USA) and Mean ﬂuorescence index (MFI)195
was calculated for each marker with the relevant isotype control196
subtracted.197
2.6. Monocyte discrimination198
To ensure that only CD14+ cells representing monocytes were199
analyzed, a gating strategy was employed to gate only HLA-DR,200
CD14 expressing cells. Brieﬂy a live gate, to include all leukocytes,201
was drawn based on forward scatter (FSC) and side scatter (SSC).202
HLA-DR positive cells were gated to exclude any CD16+ natural 203
killer (NK) cells and other non-MHC expressing cells [12], and true 204
monocytes were gated based on expression of CD14 and CD16 sur- 205
face markers. 206
2.7. Determination of exposure to P. falciparum and S. 207
haematobium 208
In order to determine if any arising differences between the 209
Caucasian and African participants were due to undetected schis- 210
tosome or Plasmodium parasite infection (current or previous) or 211
parasite-unrelated mechanisms such as genetic differences, sero- 212
logical assays were conducted to determine parasite exposure 213
history. Enzyme linked immunosorbent assay (ELISA) was  used 214
to measure antigen-speciﬁc antibodies to malaria schizont (IgG 215
and IgM) and schistosome adult worm (IgG4, IgM, IgE) in the 216
serum. Lyophilized soluble S. haematobium adult worms (SWAP) 217
was obtained from the Theodor Bilharz Institute (Giza, Egypt) 218
and reconstituted as recommended by the manufacturer. Schizont 219
extract was a kind gift from David Cavanagh (University of Edin- 220
burgh, UK). ELISAs were performed as reported elsewhere [27,28],  221
and all ELISAs were performed in duplicate on the same day with 222
positive and negative controls on each plate. 223
2.8. Statistical analysis 224
All statistical analyses were conducted using the statistical 225
package SPSS version 19. Parametric tests were used when assump- 226
tions of parametric tests were met, otherwise non-parametric 227
tests were used [29]. When using parametric tests data were 228
transformed using appropriate transformations: surface marker 229
expression (measured as MFI) was  log transformed (log10(x + 1)), 230
proportions of subsets were arcsine square root transformed, and 231
antibody responses were square root transformed. In parametric 232
models age was  taken as a continuous variable, sex (male/female) 233
and donor ethnicity (African/Caucasian) were categorical. 234
To test the hypothesis that the whole monocyte population is 235
composed of a continuum of ‘subsets’ consisting of distinct phe- 236
notypic proﬁles, differences in expression of surface markers were 237
analyzed using a one way  analysis of variance (ANOVA) with subset 238
as a grouping variable and post hoc tests used to determine sig- 239
niﬁcant differences between adjacent subsets. Differences in the 240
proportion of each subset were analyzed using an arcsine square 241
root transformation and a one way ANOVA using type I sequential 242
sums of squares in a similar manner as discussed. When sample 243
size and assumptions did not allow, the Kruskal–Wallis test was 244
used to test for differences between surface marker expression and 245
subset proportion. 246
In order to investigate the effects of cryopreservation on mono- 247
cyte phenotype with respect to changes in proportions of subsets 248
and expression of phenotypic markers, the Wilcoxon Signed Ranks 249
Test was used with processing method (fresh PBMCs vs. cryop- 250
reserved PBMCs) as grouping variable. Differences in intensity of 251
surface marker expression between subsets were determined by 252
MANOVA, allowing for sex and age using type I sequential sums of 253
squares. 254
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Fig. 1. Representative ﬂow cytometry dot plots demonstrating the gating strategy employed to deﬁne CD14+ monocytes. (A) Live gate for total leukocytes based on the
forward scatter (FSC) and side scatter (SSC) properties, (B) separation of monocytes from non HLA-DR expressing CD14 expressing NK cells prior to (C) gating total monocytes
based  on CD14 and CD16 expression.
The effects of exposure history to parasitic infection on mono-255
cyte subsets were tested by ANOVA, allowing for sex (categorical)256
and age (continuous) using type I sequential sums of squares. Dif-257
ferences in positive antibody responses to parasite antigen between258
populations were tested using the Chi-squared test for associa-259
tion after categorizing responses into positive (OD > 0) or negative260
(OD = 0). Signiﬁcant p values are reported as p ≤ 0.05 unless other-261
wise indicated.262
3. Results263
3.1. Discrimination of MHC  II positive monocytes264
Monocytes represent a population of MHCII cells that express265
varying levels of both CD14 and CD16 surface markers. Fig. 1 illus-266
trates the gating strategy used that excludes non-MHCII, CD16267
positive NK cells, but includes HLA-DR and CD14 positive mono-268
cytes. The commonly observed ‘banana’ shape that is seen with this269
cell population and the lack of clustering within the double positive270
population is demonstrated in Fig. 1C.271
3.2. Different gating strategies give different phenotypic proﬁle 272
patterns 273
There is currently no consensus on the best gating strategy of 274
monocytes with at least three different methods published that 275
involve not only different markers of deﬁnition [4,30,31] but also 276
different numbers of subsets [32–34].  Thus we  investigated if there 277
were differences in the basic phenotypic characteristics of mono- 278
cytes based on different gating strategies according to CD14 and 279
CD16 MFI. We  found stark differences in subset expression of 280
surface markers while employing different gating strategies as 281
demonstrated in Fig. 2. In sub-setting the monocytes into two 282
groups (Fig. 2 upper panels) there is an obvious difference in pat- 283
terns of expression in comparison to three groupings (Fig. 2, lower 284
panels). Expression of the phenotypic markers CX3CR1 and HLA- 285
DR is observed to be higher in the middle double positive (DP) 286
(CD14++CD16+) monocytes than in the CD16 monocytes; a dif- 287
ference which is lost in the two  subset strategy. Due to a lack of 288
clariﬁcation in the literature about the discrimination of the DP 289
monocytes, we were interested in determining if the DP expressing 290
Fig. 2. Examples of previously published gating strategies using the same representative donor as in Fig. 1. Top panel demonstrating (A) the two gating strategy based on
CD16  positive and CD16 negative monocytes, and (B) the phenotypic proﬁle associated with the two subsets. Lower panel demonstrates (C) the gating strategy of three
subsets,  regCD14, DP and regCD16 based on CD14 and CD16 expression, and (D) the associated surface marker expression proﬁle. Signiﬁcant p values are from a post hoc
one-way ANOVA. Signiﬁcant differences are indicated with * (p < 0.05) or ** (p < 0.001).
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Fig. 3. Division of monocyte population into ﬁve subsets with varying levels of expression of CD14 and CD16. (A) Representative dot plots demonstrating the division of
the  ﬁve subsets to include the traditional CD14++CD16− (regCD14), CD14+CD16++ (regCD16) and three subsets within the CD14 CD16 double positive population: dpCD14,
HLADRhi, dpCD16. (B) Pie chart illustrating the proportions, mean and (SEM) of the ﬁve subsets seen in the rural African population (n = 62). (C)–(E) Mean MFI for the rural
African  population of different monocyte phenotypic surface markers within each of the ﬁve subsets: 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: regCD16. (C)
HLA-DR, (D) CCR2 (E) CX3CR1. Signiﬁcant p values are from a post hoc one-way ANOVA. Signiﬁcant differences are indicated with * (p < 0.05) or ** (p < 0.001).
subpopulation of monocytes was a subset phenotypically distinct291
from both the CD14++CD16− and  the CD14+CD16++ monocyte292
populations. Based on expression of HLA-DR [12], we divided this293
middle population into three separate subsets to give a double pos-294
itive CD14high population (dpCD14), a double positive CD16high295
population (dpCD16) and a double positive HLA-DR high popula-296
tion (HLADRhi) (Fig. 3A). The HLADRhi designation was based on297
this group expressing the highest levels of HLA-DR (Fig. 3C). Gat-298
ing in such a manner would identify any differences occurring both299
within this group, as well as between this group and the adjacent300
subsets. For the purposes of this manuscript we wished to main-301
tain a distinction between what has been previously published and302
agreed to (three subsets deﬁned as CD14++CD16−, CD14++CD16+303
and CD14+CD16++) and the monocyte groupings as we deﬁned304
them here. We  thus decided to designate the CD14++CD16−  as305
regCD14 monocytes and the CD14+CD16++ as regCD16 monocytes.306
The gating of all ﬁve subsets is shown in Fig. 3A with the proportions307
of each of the subsets illustrated in Fig. 3B.308
3.3. Rather than distinct subsets, the monocyte gate consists a309
spectrum of progressively changing phenotypic markers310
From the larger cohort of 62 Africans we analyzed the ﬁve mono-311
cyte groupings with respect to changes in their surface expression312
of the phenotypic markers CCR2 and CX3CR1, and the MHC  recep-313
tor HLA-DR. Fig. 3C–E shows the mean expression levels of these314
markers in each of the monocyte groupings. The signiﬁcantly315
elevated level of HLA-DR in the HLADRhi subset compared to316
dpCD16 (p < 0.001) and the regCD14 cells (p < 0.001) may  indi-317
cate an increased activation status in these cells (Fig. 3C). CCR2318
shows a spectrum of expression levels with the highest on the319
regCD14 monocytes, decreasing with increasing CD16 expression320
(Fig. 3D). The CD14high expressing monocytes (regCD14, dpCD14321
and HLADRhi) do not show signiﬁcant differences in CCR2 expres- 322
sion, however with increasing CD16 expression (transitioning 323
the subset from regCD14 towards regCD16) there is a concur- 324
rent decrease in CCR2 expression (from HLADRhi to dpCD16: MFI  325
difference = −55.48, p = 0.001, and from dpCD16 to regCD16 MFI  326
difference = −63.68, p < 0.001). In contrast, CX3CR1 shows signiﬁ- 327
cant differences in expression level across all subsets (Fig. 3E), with 328
the lowest expression of CX3CR1 on CD14++ monocytes (regCD14 329
and dpCD14) as previously reported [35]. Interestingly, the high- 330
est expression is in the dpCD16 monocytes with a signiﬁcant 331
decrease in expression between dpCD16 and regCD16 mono- 332
cytes (dpCD16 to regCD16 MFI  difference = −14,414, p < 0.001) 333
(Fig. 3E). The regCD16 monocytes show a signiﬁcant decrease in 334
marker expression compared to dpCD16 for all analyzed markers 335
(Fig. 3C–E). 336
3.4. Total monocyte number but not subset proportion differs 337
between fresh and cryopreserved PBMCs 338
To investigate whether monocytes change their expression lev- 339
els and phenotype dependent on cryopreservation, nine donors 340
of Caucasian or African descent, with predominantly urban back- 341
grounds, had a collection of peripheral blood for PBMC puriﬁcation 342
and cryopreservation. In a second blood draw, fresh PBMCs were 343
puriﬁed, and these were stained on the same day as their cryop- 344
reserved cells. Cryopreserved cells show a greater proportion of 345
monocytes as a percentage of live gated cells, as shown in Fig. 4A 346
(z = −2.67, p = 0.004). However there were no signiﬁcant differences 347
in the proportion of subsets as tested by one-way ANOVA and 348
repeated measures as shown in Fig. 4B. Differences in cell surface 349
expression between fresh and cryopreserved monocytes are indi- 350
cated in Fig. 5. No differences are seen in CD14, HLA-DR or CCR2 351
expression (Fig. 5A, C and D), but signiﬁcant differences are seen in 352
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Fig. 4. Differences between fresh and cryopreserved PBMCs from 9 individuals with
an  urban background (African: n = 5; Caucasian: n = 4) were compared. (A) Fresh and
cryopreserved monocytes as frequency of live gated population. Monocytes from
fresh PBMCs show a signiﬁcantly smaller proportions of monocytes in comparison
to  cryopreserved PBMCs, measured non-parametrically with Wilcoxon Signed Ranks
Test (z = −2.67, p = 0.004). (B) Mean and SEM of proportions of the ﬁve subsets in fresh
and cryopreserved preparations. 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5:
regCD16. Open bars: fresh PBMCs; closed bars: cryopreserved PBMCs. There are no
signiﬁcant differences in proportions dependant on preparation method (measured
non-parametrically using the Wilcoxon signed ranks test).
almost all subsets for CD16 and CX3CR1 surface expression (Fig. 5B 353
and E, respectively), with fresh PBMCs showing a higher MFI  for all 354
subsets in both markers. 355
3.5. African and Caucasian donors show differences in 356
proportions of monocyte subsets 357
As the majority of studies investigating monocytes have taken 358
place in high income areas, we  were interested in whether the 359
phenotypic patterns we  have characterized were a feature of the 360
study population or if they can be transferred across populations. 361
We  therefore undertook an investigation to phenotype mono- 362
cytes from donors of different ethnicities. Fig. 6A–C illustrates 363
the differences seen in ﬂow analysis between (A) rural African 364
monocytes (B) urban African monocytes and (C) Caucasian mono- 365
cytes. There is a stark difference in the proportion of CD16 and 366
CD14 expressing subsets between the ethnicities. Fig. 6D shows 367
the proportions of the ﬁve subsets in the whole African and Cau- 368
casian populations that we  sampled. Caucasians are exhibiting a 369
signiﬁcantly greater proportion of regCD14 cells compared to rural 370
Africans (Fig. 6D, 1), while monocytes from Africans have a sig- 371
niﬁcantly greater proportion of all other subsets except dpCD14 372
(Fig. 6D, 2–5). Fig. 7 shows the differences in expression levels of 373
surface markers between these subsets for the rural African and 374
Caucasian groups. Interestingly, while the surface marker MFIs 375
between the two  populations are not always similar, they follow 376
the same pattern of expression for all subsets. The surface expres- 377
sion of the activation marker HLA-DR is higher on the rural African 378
population, predominantly in the CD14high monocytes (Fig. 7A). 379
Similarly, CCR2 is signiﬁcantly higher on rural African monocytes 380
in the regCD14 and dpCD14 groups (Fig. 7B). The expression of the 381
chemokine and adhesion receptor CX3CR1 is higher in the Cau- 382
casian cohort, although this is only signiﬁcant in the dpCD14 subset 383
(Fig. 7C). 384
Fig. 5. Differences observed in cell surface phenotype between fresh (open bar, n = 9) and cryopreserved (closed bar, n = 9) preparations of cells. (A) CD14, (B) CD16, (C)
HLA-DR, (D) CCR2 and (E) CX3CR1. 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: regCD16. Signiﬁcant differences (p < 0.05) are from nonparametric Wilcoxon signed
rank  test and are indicated with *.
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Fig. 6. Top Panel (A)–(C) representative CD14/CD16 dot plots of monocytes from (A) a rural African donor, (B) an urban African donor and (C) a Caucasian donor. Cells are
gated  according to the strategy described in Fig. 1. Bottom panel (D) Bar graphs illustrating the differences in mean and SEM of monocyte subset proportions between rural
Africans (n = 21, ﬁlled bars), Africans from urban environments (n = 5, grey bars) and Caucasians (n = 2, open bars). 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: regCD16.
P  values are from the Mann–Whitney test with an applied Bonferonni correction. Signiﬁcant p values (p < 0.0167) are indicated in bold.
3.6. Caucasians and rural Africans demonstrate different histories385
of parasite exposure386
In order to understand whether the observed differences in387
subset proportions between the different populations are due to388
history of exposure to parasitic exposure, we were interested389
in antibody responses to both P. falciparum and S. haematobium390
antigens. Fig. 8 shows the antibody responses to P. falciparum sch- 391
izont antigens (upper panels A and B) and SWAP (lower panels C and 392
D). There was very little IgM antibody response to malaria schizont 393
in either the rural African or Caucasian populations, indicating that 394
neither group had recent exposure to the parasite (Fig. 8A). In con- 395
trast, the rural Africans had a greater IgG response to the schizont 396
antigen in comparison to the Caucasians (F = 8.042, p = 0.009), as 397
Fig. 7. Mean expression levels of surface markers between rural Africans (closed bars, n = 21) and Caucasians (open bars, n = 21) based on surface marker by subset. (A)
HLA-DR, (B) CCR2, (C) CX3CR1. 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: regCD16. Signiﬁcant p values from Mann Whitney test are represented by * (p ≤ 0.05) and
**  (p ≤ 0.001).
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Fig. 8. Antibody responses of rural Africans (closed circles, n = 15) and Caucasians (open squares, n = 16) to parasite antigens. (A) IgM and (B) IgG response to malaria schizont.
(C)  IgM and (D) IgE responses to S. haematobium adult worms  (SWAP) as measured by ELISA. Signiﬁcant p-values are from Type I sequential sums of squares and are indicated
with  * (p < 0.05).
evidence of previous exposure (Fig. 8B) [36,37].  IgM against SWAP398
is associated with recent exposure to schistosomiasis, and both399
populations showed low levels of SWAP speciﬁc IgM, although the400
rural African population shows slightly elevated levels in compar-401
ison to the Caucasians (Fig. 8C) (mean OD = 0.579, Standard error402
of mean (SEM) = 0.021 and mean OD = 0.497, SEM = 0.033 respec-403
tively). As both groups are negative for schistosomiasis deﬁned404
by egg count in urine, the low IgM response is not surprising. IgE405
against SWAP is associated with cumulative history of exposure406
to the parasite antigen. Fig. 8D shows that there is no signiﬁcant407
difference between the rural African and Caucasian populations408
with regards to IgE responses (F = 3.684, p = 0.066). However the409
number of IgE positive responders to SWAP in the African group is410
signiﬁcantly greater than the number of IgE positive responders to411
SWAP in the Caucasian group (80% and 37.5% positive responders412
respectively; 2 (2) = 5.743, p = 0.017). Taken together this indicates413
that while neither population is demonstrating current exposure414
to either plasmodium or schistosome parasite infection, the rural415
Africans have had more history of exposure to the schistosome416
adult worm and are showing signs of developing immunity to the417
parasite.418
4. Discussion419
In humans, the three identiﬁed monocyte subsets have dif-420
fering migration, maturation and functional potential [4,35],  and421
there have been reports of an increase in the CD14+CD16++ sub-422
set in numerous pathologies [5,8,38–40],  however the deﬁnition423
of CD14+CD16++ monocytes varies within each of these studies.424
By dividing the monocytes into ﬁve separate subsets, we  have425
demonstrated that the CD14++CD16+ subset is made up of a phe-426
notype with signiﬁcant variation in the expression levels of typical427
markers. The decision to subdivide what is commonly known as428
the CD14++CD16+ subset was based on inconsistency within the429
ﬁeld as to where this division lay, combined with the observa- 430
tion that HLA-DR is expressed most highly by what we  deﬁned 431
as the HLADRhi subset [9,12].  As HLA-DR is an activation marker 432
[41,42] this may  indicate a functional role for these monocytes 433
that is not shared by either of the dpCD14 or dpCD16 monocytes. 434
This method of division of the middle CD14+CD16++ monocyte 435
population gives a clear indication that there is a progressive 436
pathway between the monocyte subsets. This continuum may  437
not be surprising considering recent murine data demonstrating 438
that the Ly6C+ monocytes (correlate of human CD14++CD16+ and 439
CD14++CD16− monocytes) are precursors of Ly6C− monocytes 440
(correlate of human CD14+CD16++) [43]. 441
CCR2 and CX3CR1 are chemokine receptors that have frequently 442
been reported to have disparate afﬁliations with monocyte subsets 443
[3,35].  Here we report no signiﬁcant differences in CCR2 expression 444
within CD14++ expressing subsets, with signiﬁcant differences in 445
expression only occurring with the onset of CD16 expression. In 446
contrast CX3CR1 expression shows a clear distinction in expression 447
levels within each of the ﬁve subsets and differential expres- 448
sion between the dpCD16 and regCD16 monocytes. As CX3CR1 449
is involved in adhesion to the blood vessel wall and with rapid 450
extravasation of the cell [11], this may  be indicative of a separate 451
function for the regCD16 (CX3CR1low) monocytes and the dpCD16 452
(CX3CR1high) monocytes. Indeed the regCD16 subset consistently 453
shows signiﬁcant decreases in surface marker expression to the 454
dpCD16 subset. 455
Due to time or physical restrictions, as well as for longitudinal 456
cohort studies, many research protocols including our own  require 457
cryopreservation of PBMCs before processing and staining for ﬂow 458
cytometry. Therefore we investigated whether there were changes 459
in these deﬁned ﬁve subsets based on processing of the cells. We  460
show that total monocyte numbers were reduced following cry- 461
opreservation. However, there were no signiﬁcant differences in 462
the proportions of each of the subsets. The MFI  of CD14 and CD16 463
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were examined, in particular as the MFI  of CD16 has been reported464
to be upregulated with activation [44,45]. The CD16 receptor was465
expressed to a higher intensity on fresh than cryopreserved cells.466
Similarly CX3CR1 showed a signiﬁcantly higher MFI  in each sub-467
set for the fresh PMBCs. These differences may  be a consequence468
of the freezing process, perhaps inﬂuencing the stability of these469
markers and preventing a rapid activation of the thawed cells in470
the same manner as the fresh preparation. Previous studies have471
found no differences in frozen and fresh PBMCs with regards to T472
cell proportion and function [46] as well as macrophage differenti-473
ation [22]. Here we have found that while the MFI  between the two474
preparations can alter, the patterns remain robust, indicating that475
while the two  methods are comparable they should not be used to476
see within experiment differences.477
For any study evaluating interventions that may  alter blood478
monocytes, it is important to know if genetic and environmental479
background differences between individuals impact on monocyte480
subset balance. We  show here that such differences do exist in481
Africans and Caucasians, with Africans exhibiting a greater pro-482
portion of CD16 expressing subsets compared to Caucasians. All483
individuals were negative for helminth infections, malaria and484
HIV. However, the rural African population did show evidence of485
past exposure to malaria and schistosomiasis infection. In many486
pathologies frequently occurring in urban environments, such487
as asthma, microbial infection and arthritis, there is a reported488
increase in the CD14++CD16+ and CD14+CD16++ subsets, which489
may  be indicative of an activated immune system [8,38,39].490
Knowledge of these baseline subset differences is important for491
undertaking studies in environments where exposure to numerous492
pathogens is common, as changes seen with other infections may493
not be as distinct. Interestingly, the pattern of monocyte subsets in494
the African group living in a western environment lay between the495
Caucasians and the rural Africans exposed to schistosomiasis. This496
indicates that the differences seen in the subset patterns may  be497
more of a function of exposure to parasites than genetics. However,498
this group of individuals was small, and only one was originally499
from Zimbabwe, where the rural Africans originated from. There is500
reportedly more human genetic diversity within Africa than in the501
rest of the world so these differences could be as much to do with502
genetic differences between the populations as with the exposure503
history [47]. In terms of differences in phenotype of the mono-504
cyte subsets, similar to the preparations of the cells, the pattern505
of expression of the subset markers remained the same between506
the different ethnicities. Previous reports have shown that CCR2 is507
low to negative on CD16 expressing monocytes [31], whereas our508
group, in studying PBMCs isolated from individuals in Zimbabwe,509
has always found evidence of a certain expression level of this510
marker (unpublished data). We  show here that the PBMCs from511
rural Africans express CCR2 to a greater intensity in comparison to512
Caucasians, particularly in the CD14 expressing monocytes. Over-513
all, expression of HLA-DR was higher in the rural African population514
than in Caucasians. As an activation marker that is rapidly upregu-515
lated with infection, the HLA-DR expression level may  be indicating516
recent exposure to infection or, perhaps an impaired ability to shed517
HLA-DR into the serum in response to inﬂammation [13,14,48].518
CX3CR1 showed a tendency towards higher expression in Cau-519
casian monocytes similar to CD16 expression (data not shown) and520
is in agreement with the differences in CD16 observed with prepa-521
ration differences. Previously reported associations between CD16522
and CX3CR1, as well as with CD14 and CCR2, make it unsurpris-523
ing that the signiﬁcant differences are seen in the same direction524
between these markers within these populations. Taken together525
it is clear that while monocyte subset markers do not change pat-526
tern between different populations, the expression levels, as well527
as proportions of subsets can be signiﬁcantly different. This may528
be due to a lifetime of exposure to pathogens, such as malaria529
and schistosomiasis, and the immune response associated with this 530
exposure. Whilst the sample size reported on is small, the ﬁndings 531
do highlight the importance of taking care when comparing results 532
from different experiments, or in recruiting individuals into a study. 533
Further research into differences in monocyte subsets based on eth- 534
nic background would be valuable in fully understanding the extent 535
of these differences. 536
5. Conclusions 537
In this study we present data demonstrating the spectrum of 538
maker expression within the recently deﬁned subsets of human 539
monocytes [4].  With direct relevance to research in the ﬁeld we 540
show that there are few changes in these subsets or expression 541
of surface markers in response to cryopreservation. We  also show 542
that expression levels of typical markers for monocyte function 543
do change in intensity based on ethnic background of the individ- 544
ual. While the scope of this study does not allow for determining 545
what drives these changes, it does emphasize the important role 546
monocytes have in exposure to disease. 547
Our study focused on surface marker expression, but it will be 548
interesting to assess differences in intracellular markers, cytokine 549
secretion and particularly functional capabilities within these ﬁve 550
subsets. Whilst sorting the cells in large enough quantities for func- 551
tional analysis may  be a challenge, using this monocyte gating 552
technique we  have shown that there is a shifting spectrum of phe- 553
notypic markers that may  lead to clues as to the function of each of 554
the monocyte subsets. Importantly our study indicates that confor- 555
mity across research groups in gating of these subsets is necessary 556
in order to compare studies. 557
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